发明名称 |
TUMOUR THERAPY |
摘要 |
A three component therapeutic system comprising (i) a first compound, (ii) a catalytic macromolecule which does not specifically bind to a tumour antigen but which is capable, following administration to the vascular compartment of a mammal, of being taken up by a tumour in the mammal and is capable of converting the first compound into a second compound, and (iii) an inhibitor which, following administration to the said vascular compartment, reduces the level of the said catalytic conversion activity in the vascular compartment. |
申请公布号 |
WO9824478(A2) |
申请公布日期 |
1998.06.11 |
申请号 |
WO1997GB03284 |
申请日期 |
1997.11.28 |
申请人 |
AEPACT LIMITED;BAGSHAWE, KENNETH, DAWSON |
发明人 |
BAGSHAWE, KENNETH, DAWSON |
分类号 |
A61K38/43;A61K39/395;A61K45/00;A61K47/48;A61P35/00;A61P43/00 |
主分类号 |
A61K38/43 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|